🩸 Why Do Blood Samples Develop Clots? — Causes, Laboratory Impact, and Why Clotted Specimens Must Be Rejected

Clotting in blood specimens is more common than many expect. Even small, barely visible partial clots can significantly distort laboratory test results. For this reason, clotted specimens are one of the most important rejection criteria in clinical laboratories.

This article explains why clots form, how they affect CBC, coagulation tests, and chemistry results, and how to prevent clots during blood collection.

---

🔍 1. Why Do Clots Form in Blood Samples?

A clot is formed when blood collected in a tube undergoes coagulation. Because blood naturally clots when exposed to surfaces, laboratories use anticoagulants such as EDTA, sodium citrate, or heparin to prevent this.

However, clot formation may still occur due to several preanalytical factors.

✔ 1) Incorrect blood-to-anticoagulant ratio

Optimal ratio for EDTA tubes: 9 : 1 (blood : EDTA)

If the tube is underfilled, the anticoagulant becomes insufficient, and clotting occurs.
This is one of the most common causes of partial clots.

✔ 2) Insufficient mixing after collection

Tubes containing anticoagulant must be gently inverted 8–10 times immediately after collection.
Without adequate mixing, anticoagulant contact is uneven → localized clot formation.

✔ 3) Slow blood draw or turbulent flow

Cases that increase risk:

• Very slow collection
• Needle touching vessel wall
• Difficult venipuncture

These situations reduce the immediate contact between blood and anticoagulant.

✔ 4) Difficult draw

Clots are more likely when:

• Vein collapses
• Multiple needle attempts
• Extremely viscous blood

✔ 5) Delay after collection

If the specimen is not mixed or transported promptly, coagulation mechanisms activate over time → clot formation increases.

---

🧪 2. How Do Clots Affect Laboratory Test Results?

If any clot is present, the specimen must be rejected because clotting alters blood cell counts and consumes coagulation factors.

🩺 1) Effects on CBC (Complete Blood Count)

① WBC – falsely low

White blood cells adhere to or become trapped in the clot → analyzer detects fewer cells.

Severe cases may show 50% or more reduction in WBC count.

② Platelets – falsely low (pseudothrombocytopenia)

Platelets are highly reactive.
They attach to fibrin strands early in clot formation → markedly decreased PLT count.

③ RBC, Hct, Hb – inaccurate

Red cells can also become trapped, leading to:

• Low RBC count
• Altered Hct/Hb
• Distorted MCV, RDW

④ Peripheral smear abnormalities

Partial clots cause:

• Uneven smear distribution
• Fibrin threads visible
• Clumped cells
  → CBC results cannot be trusted.

---

🧵 2) Effects on Coagulation Tests (PT, aPTT)

In citrate tubes, clot presence makes coagulation testing invalid.

Why?

• Clot formation consumes coagulation factors (fibrinogen, factor V, VIII)
  → PT/aPTT become falsely prolonged
  → Does not reflect the patient’s true hemostatic status.

---

🧬 3) Effects on Other Tests

✔ Fibrinogen, D-dimer, FDP

Fibrinogen is consumed during clotting → falsely low levels.

✔ ESR

Clotting interferes with rouleaux formation → unreliable ESR values.

✔ Chemistry assays

Because blood cells are trapped or lysed in clots, certain analytes may show bias in:

• Electrolytes
• Enzymes
• Proteins

---

⚠️ 3. Why Clotted Specimens Must Be Rejected

Even a 1-mm clot can render the entire sample invalid.

Summary of reasons:

• Blood cells become trapped → CBC inaccuracy
• Coagulation factors are consumed → false PT/aPTT prolongation
• Fibrin strands interfere with analyzers
• Partial clots may be invisible → silent analytical error risk
• Incorrect results may lead to misdiagnosis or inappropriate treatment

Therefore, according to international laboratory standards, clotted samples must be redrawn, although some labs add a remark if partial clotting is suspected.

---

🧷 4. How to Prevent Clots During Blood Collection

Practical tips for phlebotomists:

• Immediately invert EDTA/citrate tubes 8–10 times
• Ensure tubes are filled to the correct volume
• Avoid excessively slow draws
• Consider using a heparin tube in difficult draws
• Transport the specimen promptly—do not leave it standing
• Adjust anticoagulant volume for patients with high hematocrit

Proper technique significantly reduces clot-related specimen rejections.

---

📚 References

Clinical and Laboratory Standards Institute (CLSI). GP41 — Collection of Diagnostic Venous Blood Specimens, 7th ed.
Clinical and Laboratory Standards Institute (CLSI). H26 — Validation of Hematology Analyzer, 2nd ed.
McPherson & Pincus. Henry’s Clinical Diagnosis and Management by Laboratory Methods.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th ed.
Lippi G et al. “Preanalytical quality improvement: from dream to reality.” Clin Chem Lab Med.
Froom P et al. “Clotted hematology samples.” Arch Pathol Lab Med.